350 related articles for article (PubMed ID: 20594138)
1. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease.
Bousvaros A
Expert Rev Clin Immunol; 2010 Jul; 6(4):659-66. PubMed ID: 20594138
[TBL] [Abstract][Full Text] [Related]
2. [Biological therapy as treatment of inflammatory bowel diseases].
Agnholt J
Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
[TBL] [Abstract][Full Text] [Related]
3. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.
Schneeweiss S; Korzenik J; Solomon DH; Canning C; Lee J; Bressler B
Aliment Pharmacol Ther; 2009 Aug; 30(3):253-64. PubMed ID: 19438424
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
Hibi T; Iwao Y; Yajima T; Inoue N; Ueno Y; Takaishi H; Watanabe M; Ishii H
J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
[TBL] [Abstract][Full Text] [Related]
5. Management of inflammatory bowel disease in adults.
Katz JA
J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease therapy: current state-of-the-art.
Blonski W; Buchner AM; Lichtenstein GR
Curr Opin Gastroenterol; 2011 Jul; 27(4):346-57. PubMed ID: 21654383
[TBL] [Abstract][Full Text] [Related]
7. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
8. Medical management of patients with difficult-to-treat inflammatory bowel disease.
van Hogezand RA
Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Markowitz J; Grancher K; Mandel F; Daum F
Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
[TBL] [Abstract][Full Text] [Related]
10. Review article: chronic active disease and maintaining remission in Crohn's disease.
Kamm MA
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
Korelitz BI
Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
[TBL] [Abstract][Full Text] [Related]
12. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
13. The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
Melmed GY; Spiegel BM; Bressler B; Cheifetz AS; Devlin SM; Harrell LE; Irving PM; Jones J; Kaplan GG; Kozuch PL; Velayos FS; Baidoo L; Sparrow MP; Siegel CA
Clin Gastroenterol Hepatol; 2010 Aug; 8(8):655-9. PubMed ID: 20451665
[TBL] [Abstract][Full Text] [Related]
14. Review article: monitoring of immunomodulators in inflammatory bowel disease.
Aberra FN; Lichtenstein GR
Aliment Pharmacol Ther; 2005 Feb; 21(4):307-19. PubMed ID: 15709982
[TBL] [Abstract][Full Text] [Related]
15. Update on idiopathic colitides.
Strobel S; Abreu MT
Curr Opin Gastroenterol; 2013 Jan; 29(1):60-5. PubMed ID: 23207597
[TBL] [Abstract][Full Text] [Related]
16. Are patients with inflammatory bowel disease receiving optimal care?
Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
[TBL] [Abstract][Full Text] [Related]
17. Managing complicated Crohn's disease in children and adolescents.
Homan M; Baldassano RN; Mamula P
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):572-9. PubMed ID: 16327836
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of infliximab in the course of treatment of Crohn's disease.
Bratcher JM; Korelitz BI
Expert Opin Drug Saf; 2006 Jan; 5(1):9-16. PubMed ID: 16370952
[TBL] [Abstract][Full Text] [Related]
19. The safety of biologic agents in the treatment of inflammatory bowel disease.
Shepela C
Minn Med; 2008 Jun; 91(6):42-5. PubMed ID: 18616021
[TBL] [Abstract][Full Text] [Related]
20. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
Present DH
Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
